Aisner J - Search Results

1

Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia.

Saraiya B, Gounder M, Dutta J, Saleem A, Collazo C, Zimmerman L, Nazar A, Gharibo M, Schaar D, Lin Y, Shih W, Aisner J, Strair RK, Rubin EH. Saraiya B, et al. Among authors: aisner j. Anticancer Drugs. 2008 Apr;19(4):411-20. doi: 10.1097/CAD.0b013e3282f5218b. Anticancer Drugs. 2008. PMID: 18454051 Clinical Trial.

2

Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy.

Licitra EJ, Vyas V, Nelson K, Musanti R, Beers S, Thomas C, Poplin E, Smith S, Lin Y, Schaaf LJ, Aisner J, Gounder M, Rajendra R, Saleem A, Toppmeyer D, Rubin EH. Licitra EJ, et al. Among authors: aisner j. Clin Cancer Res. 2003 May;9(5):1673-9. Clin Cancer Res. 2003. PMID: 12738720 Clinical Trial.

3

Sequencing topotecan and etoposide plus cisplatin to overcome topoisomerase I and II resistance: a pharmacodynamically based Phase I trial.

Aisner J, Musanti R, Beers S, Smith S, Locsin S, Rubin EH. Aisner J, et al. Clin Cancer Res. 2003 Jul;9(7):2504-9. Clin Cancer Res. 2003. PMID: 12855624 Clinical Trial.

4

Nuclear factor-kappaB modulation in patients undergoing induction chemotherapy for acute myelogenous leukemia.

Strair RK, Gharibo M, Schaar D, Rubin A, Harrison J, Aisner J, Lin HC, Lin Y, Goodell L, Anand M, Balsara B, Dudek L, Rabson A, Medina DJ. Strair RK, et al. Among authors: aisner j. Clin Cancer Res. 2008 Nov 15;14(22):7564-8. doi: 10.1158/1078-0432.CCR-08-1390. Clin Cancer Res. 2008. PMID: 19010875 Clinical Trial.

5

A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies.

Schaar D, Goodell L, Aisner J, Cui XX, Han ZT, Chang R, Martin J, Grospe S, Dudek L, Riley J, Manago J, Lin Y, Rubin EH, Conney A, Strair RK. Schaar D, et al. Among authors: aisner j. Cancer Chemother Pharmacol. 2006 Jun;57(6):789-95. doi: 10.1007/s00280-005-0125-1. Epub 2005 Oct 18. Cancer Chemother Pharmacol. 2006. PMID: 16231182 Clinical Trial.

6

Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy.

Medina D, David K, Lin Y, Schaar D, Patel V, Gharibo M, Bannerji R, Walton K, Aisner J, Rabson AB, Strair R. Medina D, et al. Among authors: aisner j. Leuk Lymphoma. 2017 May;58(5):1227-1230. doi: 10.1080/10428194.2016.1225206. Epub 2016 Sep 23. Leuk Lymphoma. 2017. PMID: 27659510 No abstract available.

7

Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma.

DiPaola RS, Chenven ES, Shih WJ, Lin Y, Amenta P, Goodin S, Shumate A, Capanna T, Cardiella M, Cummings KB, Aisner J, Todd MB. DiPaola RS, et al. Among authors: aisner j. Cancer. 2001 Oct 15;92(8):2065-71. doi: 10.1002/1097-0142(20011015)92:8<2065::aid-cncr1546>3.0.co;2-k. Cancer. 2001. PMID: 11596021 Clinical Trial.

8

Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate.

Strair RK, Schaar D, Goodell L, Aisner J, Chin KV, Eid J, Senzon R, Cui XX, Han ZT, Knox B, Rabson AB, Chang R, Conney A. Strair RK, et al. Among authors: aisner j. Clin Cancer Res. 2002 Aug;8(8):2512-8. Clin Cancer Res. 2002. PMID: 12171877

9

Antineoplastic effects of partially HLA-matched irradiated blood mononuclear cells in patients with renal cell carcinoma.

Strair RK, Schaar D, Medina D, Todd MB, Aisner J, DiPaola RS, Manago J, Knox B, Jenkinson A, Senzon R, Baker C, Liesel D, Ciardella M, Kuriyan M, Rubin A, Lattime EC. Strair RK, et al. Among authors: aisner j. J Clin Oncol. 2003 Oct 15;21(20):3785-91. doi: 10.1200/JCO.2003.05.094. J Clin Oncol. 2003. PMID: 14551297 Clinical Trial.

10

A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies.

Tan AR, Chan N, Kiesel BF, Stein MN, Moss RA, Malhotra J, Aisner J, Shah M, Gounder M, Lin H, Kane MP, Lin Y, Ji J, Chen A, Beumer JH, Mehnert JM. Tan AR, et al. Among authors: aisner j. Cancer Chemother Pharmacol. 2022 Jan;89(1):49-58. doi: 10.1007/s00280-021-04350-x. Epub 2021 Oct 20. Cancer Chemother Pharmacol. 2022. PMID: 34669023 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters